EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Can we improve the management of inoperable malignant bowel obstruction? Results of a feasibility study of elemental diet as an alternative to parenteral nutrition in patients with advanced gynaecological cancer

Lindsey L Allan, Simon S Skene, Kate Bennett Eastley, Rebecca Herbertson, Eleanor Smith, Agnieszka Michael

Supportive Care in Cancer · 2024

DOI: 10.1007/s00520-024-08709-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Supportive Care in Cancer, 2024. Verfasst von Lindsey L Allan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Royal Surrey NHS Foundation Trust, Egerton Road, Guildford, GU2 7XX, United Kingdom. Hauptthemen laut MEDLINE: Feasibility Studies, Quality of Life, Intestinal Obstruction, Genital Neoplasms, Female. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Target Ovarian Cancer.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Nutrition support in inoperable bowel obstruction (IBO) remains challenging. Parenteral nutrition (PN) is recommended if the prognosis is > 2 months. An elemental diet (ED) is licensed for strictures in Crohn’s disease but has not been used in malignant bowel obstruction. The aim of this study was to evaluate the use of ED in patients with IBO and provide a proof of concept of ED as an acceptable feeding option.

Methods

This was a mixed-methods single-arm feasibility study. The primary endpoint was to provide a ‘proof of concept’ of ED as an acceptable feeding option for patients with IBO. Secondary endpoints included taste acceptability, incidences of vomiting and pain, the proportion of women who tolerated ED, the number of cartons drunk, quality of life (QOL) and the number of women treated with chemotherapy. Patients (> 18 years) with CT-confirmed IBO who could tolerate 500 ml of liquid in 24 h remained on the trial for 2 weeks.

Results

A total of 29 patients were recruited; of those, 19 contributed to the analysis for the primary endpoint; 13 (68.4%) participants tolerated the ED; 26 patients contributed to MSAS and EORTC QLQ questionnaires at baseline to allow for the assessment of symptoms. At the start of the study, 18 (69%) of patients experienced vomiting, reducing to 4 (25%) by the end of day 15 of the study; 24 (92%) of patients reported pain at consent, reducing to 12 (75%) by the end of day 15. QOL scores improved from 36.2 (95% CI 27.7–44.7) at baseline to 53.1 (95% CI 40.3–66) at the end of day 15; 16 (84%) participants commenced chemotherapy within the first week of starting ED. The number of cartons across all participants showed a median of 1.3 cartons per day (range 0.8 to 2.5).

Conclusion

ED is well tolerated by patients with IBO caused by gynaecological malignancies and may have a positive effect on symptom burden and QOL.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Feasibility StudiesQuality of LifeIntestinal ObstructionGenital Neoplasms, FemaleParenteral NutritionFood, FormulatedHumansFemaleMiddle AgedAgedAdultAged, 80 and over

Stichwörter der Autor:innen

Elemental dietInoperable bowel obstructionOvarian cancerParenteral nutrition

Autor:innen und Institutionen

  • Royal Surrey NHS Foundation Trust, Egerton Road, Guildford, GU2 7XX, United Kingdom.
  • Surrey Clinical Trials Unit, School of Biosciences, University of Surrey, Egerton Road, Guildford, GU2 7XP, United Kingdom.
  • University Hospitals Sussex NHS Foundation Trust, Royal Sussex Hospital, Eastern Road, Brighton, BN2 5BE, United Kingdom.
  • Royal Surrey NHS Foundation Trust, Egerton Road, Guildford, GU2 7XX, United Kingdom. a.michael@surrey.ac.uk.
  • Surrey Clinical Trials Unit, School of Biosciences, University of Surrey, Egerton Road, Guildford, GU2 7XP, United Kingdom. a.michael@surrey.ac.uk.

Förderung

  • Target Ovarian Cancer

Zitieren

APA

Allan, L. L., Skene, S. S., Eastley, K. B., Herbertson, R., Smith, E., & Michael, A. (2024). Can we improve the management of inoperable malignant bowel obstruction? Results of a feasibility study of elemental diet as an alternative to parenteral nutrition in patients with advanced gynaecological cancer. Supportive Care in Cancer. https://doi.org/10.1007/s00520-024-08709-7

Vancouver

Allan LL, Skene SS, Eastley KB, Herbertson R, Smith E, Michael A. Can we improve the management of inoperable malignant bowel obstruction? Results of a feasibility study of elemental diet as an alternative to parenteral nutrition in patients with advanced gynaecological cancer. Supportive Care in Cancer. 2024. doi:10.1007/s00520-024-08709-7

BibTeX
@article{Allan2024,
  author = {Allan, Lindsey L and Skene, Simon S and Eastley, Kate Bennett and Herbertson, Rebecca and Smith, Eleanor and Michael, Agnieszka},
  title = {Can we improve the management of inoperable malignant bowel obstruction? Results of a feasibility study of elemental diet as an alternative to parenteral nutrition in patients with advanced gynaecological cancer},
  journal = {Supportive Care in Cancer},
  year = {2024},
  doi = {10.1007/s00520-024-08709-7}
}
Kostenlos starten →